Summary
Transcriptional dyregulation is a common driver in cancer and acute myeloid leukemia (AML) is an exemplar of this process. AML has a dismal survival rate of
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/647685 |
Start date: | 01-09-2015 |
End date: | 28-02-2021 |
Total budget - Public funding: | 1 999 574,00 Euro - 1 999 574,00 Euro |
Cordis data
Original description
Transcriptional dyregulation is a common driver in cancer and acute myeloid leukemia (AML) is an exemplar of this process. AML has a dismal survival rate ofStatus
CLOSEDCall topic
ERC-CoG-2014Update Date
27-04-2024
Images
No images available.
Geographical location(s)